Higher levels of Ki67 are associated with higher grades (Table 3), it was revealed that compared to patients with cancer Grade I, cancer Grade II patients were more likely to have elevated Ki67 by at least 41 times higher (95% CI = 4.36–63.8; p = 0.001), while for cancer Grade III patients, likelihood was 7.43 times higher (95% CI =3.68–14.99; p < 0.001). The gene discussed is MKI67; the disease is cancer.